financetom
Business
financetom
/
Business
/
AstraZeneca lifts full-year outlook on upbeat demand for therapies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca lifts full-year outlook on upbeat demand for therapies
Jul 24, 2024 11:23 PM

July 25 (Reuters) - Anglo-Swedish drugmaker AstraZeneca ( AZN )

on Thursday raised its sales and profit forecast for

2024 and topped analyst expectations for second-quarter revenue,

buoyed by demand for its therapies for cancer and rare diseases.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved